Juvenile Arthritis

07 Jul 2021

Posted at 10:38h in JA, Juvenile Arthritis, Juvenile Arthritis Research, The ANRF Chronicle by

Biologics have been viewed as the new “it” drug to treat autoimmune conditions. These drugs are manufactured in, extracted from, or semi-synthesized from biological sources. Monoclonal antibodies are a form of biologic treatment that are similar to our own immune system antibodies. They can be...

18 Feb 2021

Posted at 18:12h in Juvenile Arthritis, Juvenile Arthritis Research, The ANRF Chronicle by

Dr. Lauren Henderson received a BA from Cornell University with majors in neurobiology and psychology. She was first exposed to the importance of clinical research through Postbaccalaureate Intramural Research and Training Program at the National Institutes of Health. After a year at NIH, she moved...

10 Dec 2018

Posted at 07:57h in Autoimmune, Juvenile Arthritis, Juvenile Arthritis Research, Rheumatoid Arthritis, Rheumatoid Arthritis Research by

Peter A. Nigrovic, MD, is Associate Professor of Medicine at Harvard Medical School and Associate Physician at Brigham and Women’s Hospital. He is a practicing adult and pediatric rheumatologist and director of the Center for Adults with Pediatric Rheumatic Illness (CAPRI) at the Brigham and...

Skip to content